Sandra Riccaldi

miR-495-3p Sensitizes BCR::ABL1 Expressing Leukemic cells to Tyrosine Kinase Inhibitors by Targeting Multidrug Resistance 1 Gene including in T315I Mutated cells

A. Bennaceur-Griscelli, C. Desterke, A. Turhan, 2022, bioRxiv.

miR-495-3p sensitizes BCR-ABL1-expressing leukemic cells to tyrosine kinase inhibitors by targeting multidrug resistance 1 gene in T315I mutated cells.

A. Bennaceur-Griscelli, C. Desterke, A. Turhan, 2022, Experimental hematology.